Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GVAX in hormone-naïve prostate cancer
NCT00140387Phase 2Completed
- Sponsor
- Cell Genesys
- Start
- May 1999
- Modality
- Cancer Vaccines, Adoptive Cell Transfer
01
Overview
A Phase 2 trial of GVAX Prostate in prostate cancer (PCa), sponsored by Cell Genesys. Started May 1999; status: completed.
02
Drugs
GVAX Prostate
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00140387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140387.